VYGR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Voyager Therapeutics Inc

NASDAQ | VYGR

4.48

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$236.30M

Market Cap

-

P/E Ratio

-1.86

EPS

$8.27

52 Week High

$2.65

52 Week Low

HEALTHCARE

Sector

VYGR Chart

Recent Chart
Price Action

VYGR Technicals

Tags:

VYGR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $80M
Total Revenue $80M
Cost Of Revenue $4.7M
Costof Goods And Services Sold $4.7M
Operating Income -$83M
Selling General And Administrative $36M
Research And Development $127M
Operating Expenses $163M
Investment Income Net -
Net Interest Income $18M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.7M
Income Before Tax -$64M
Income Tax Expense $665K
Interest And Debt Expense -
Net Income From Continuing Operations -$65M
Comprehensive Income Net Of Tax -
Ebit -$83M
Ebitda -$79M
Net Income -$65M

Revenue & Profitability

Earnings Performance

VYGR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $393M
Total Current Assets $277M
Cash And Cash Equivalents At Carrying Value $71M
Cash And Short Term Investments $71M
Inventory -
Current Net Receivables $4.5M
Total Non Current Assets $116M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $66M
Short Term Investments $195M
Other Current Assets $5.6M
Other Non Current Assets -
Total Liabilities $93M
Total Current Liabilities $50M
Current Accounts Payable $4M
Deferred Revenue -
Current Debt -
Short Term Debt $7.2M
Total Non Current Liabilities $44M
Capital Lease Obligations $44M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $44M
Other Current Liabilities $14M
Other Non Current Liabilities $1M
Total Shareholder Equity $300M
Treasury Stock -
Retained Earnings -$326M
Common Stock $55K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4.7M
Capital Expenditures $3.5M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$95M
Cashflow From Financing $114M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $19M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$65M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $80M
Total Revenue $80M
Cost Of Revenue $4.7M
Costof Goods And Services Sold $4.7M
Operating Income -$83M
Selling General And Administrative $36M
Research And Development $127M
Operating Expenses $163M
Investment Income Net -
Net Interest Income $18M
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.7M
Income Before Tax -$64M
Income Tax Expense $665K
Interest And Debt Expense -
Net Income From Continuing Operations -$65M
Comprehensive Income Net Of Tax -
Ebit -$83M
Ebitda -$79M
Net Income -$65M

VYGR News

VYGR Profile

Voyager Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Voyager Therapeutics Inc. (VYGR) is a clinical-stage gene therapy company headquartered in Cambridge, Massachusetts, dedicated to advancing innovative treatments for severe neurological diseases. Utilizing its proprietary platform, Voyager aims to address chronic and debilitating conditions through precisely engineered adeno-associated virus (AAV) vectors that enable targeted and sustained delivery of therapeutic genes. With a robust pipeline of investigational therapies, the company is positioned at the forefront of neurological treatment innovation, representing significant potential for addressing unmet medical needs in the CNS space. Voyager's strategic partnerships and clinical collaborations further enhance its capability to expedite development and expand its market reach.

ADAP
+98.01%
$0.16
INTC
+22.77%
$30.57
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.84%
$0.93
BITF
+4.91%
$3.20
SNAP
+6.32%
$8.49
GPUS
+30.65%
$0.53
ATCH
-28.08%
$1.16
PLUG
+5.00%
$2.10
LASE
+69.10%
$4.73
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
RAYA
+35.57%
$0.06
GRAB
+4.09%
$6.35
FAAS
-10.53%
$0.08
TSLA
-2.11%
$416.85
ETNB
+85.14%
$14.96
AMD
-0.77%
$157.91
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
QBTS
+6.56%
$24.02
NIO
-1.14%
$7.36
SOFI
+3.57%
$28.11
TPIC
-45.91%
$0.12
PLTR
+5.13%
$176.97
BINI
-16.93%
$0.05
MULN
-16.93%
$0.05
YAAS
+14.04%
$0.07
AXDX
-61.36%
$0.03
QS
+18.22%
$12.13
BMNR
+4.78%
$59.80
CLSK
+17.65%
$13.46
TNMG
-0.27%
$0.32
DNN
+1.18%
$2.57
CJET
+9.27%
$0.10
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
BTG
-0.23%
$4.32
TLRY
+5.88%
$1.26
RR
+12.81%
$4.49
IONQ
+2.09%
$66.81
VHAI
0.00%
$0.00
ABEV
-2.54%
$2.29
BBD
-1.20%
$3.27
AAPL
-0.46%
$237.88
QUBT
+3.61%
$18.35
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
ADD
-25.47%
$0.05
AMZN
-0.16%
$231.23
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.77%
$9.25
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.41%
$24.15
WULF
-1.58%
$11.17
KEY
+2.24%
$19.13
HBAN
+1.88%
$17.87
IONZ
-4.37%
$4.59
IXHL
+2.29%
$0.54
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ORIS
+9.39%
$0.15
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
UEC
+0.16%
$12.26
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
MRVL
+4.57%
$74.23
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
REPL
-39.40%
$3.46
VALE
-0.36%
$10.84
KVUE
-1.30%
$18.10
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
JD
+0.39%
$35.38
RIG
+1.76%
$3.46
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
CAN
+1.23%
$0.81
PBM
+42.47%
$5.30
ADAP
+98.01%
$0.16
INTC
+22.77%
$30.57
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.84%
$0.93
BITF
+4.91%
$3.20
SNAP
+6.32%
$8.49
GPUS
+30.65%
$0.53
ATCH
-28.08%
$1.16
PLUG
+5.00%
$2.10
LASE
+69.10%
$4.73
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
RAYA
+35.57%
$0.06
GRAB
+4.09%
$6.35
FAAS
-10.53%
$0.08
TSLA
-2.11%
$416.85
ETNB
+85.14%
$14.96
AMD
-0.77%
$157.91
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
QBTS
+6.56%
$24.02
NIO
-1.14%
$7.36
SOFI
+3.57%
$28.11
TPIC
-45.91%
$0.12
PLTR
+5.13%
$176.97
BINI
-16.93%
$0.05
MULN
-16.93%
$0.05
YAAS
+14.04%
$0.07
AXDX
-61.36%
$0.03
QS
+18.22%
$12.13
BMNR
+4.78%
$59.80
CLSK
+17.65%
$13.46
TNMG
-0.27%
$0.32
DNN
+1.18%
$2.57
CJET
+9.27%
$0.10
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
BTG
-0.23%
$4.32
TLRY
+5.88%
$1.26
RR
+12.81%
$4.49
IONQ
+2.09%
$66.81
VHAI
0.00%
$0.00
ABEV
-2.54%
$2.29
BBD
-1.20%
$3.27
AAPL
-0.46%
$237.88
QUBT
+3.61%
$18.35
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
ADD
-25.47%
$0.05
AMZN
-0.16%
$231.23
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.77%
$9.25
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.41%
$24.15
WULF
-1.58%
$11.17
KEY
+2.24%
$19.13
HBAN
+1.88%
$17.87
IONZ
-4.37%
$4.59
IXHL
+2.29%
$0.54
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ORIS
+9.39%
$0.15
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
UEC
+0.16%
$12.26
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
MRVL
+4.57%
$74.23
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
REPL
-39.40%
$3.46
VALE
-0.36%
$10.84
KVUE
-1.30%
$18.10
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
JD
+0.39%
$35.38
RIG
+1.76%
$3.46
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
CAN
+1.23%
$0.81
PBM
+42.47%
$5.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.